Posts

Showing posts with the label Medical Device Regulation

MFDS Korea Proposes Simplifying Import Procedures for Personal-Use Medical Devices

Image
  The Ministry of Food and Drug Safety (MFDS) has announced a proposed amendment to the Regulation on Exemption from Import Requirements for Medical Devices, which would exempt patients with rare or intractable diseases who regularly import medical devices for personal use, due to the lack of alternative products available in Korea, from repeatedly submitting medical certificates with every import. ( Announcement No. 2026-127 ) Public opinions on the proposed amendment will be accepted until March 29, 2026. Key Changes A medical certificate (or opinion letter) will only need to be submitted only once at the initial application when applying for an import requirement exemption for personal-use medical devices. For subsequent imports, the import requirement confirmation shall be substituted with the previously submitted medical certificate (or opinion letter). The MFDS is expected to reduce the economic and administrative burden associated with obtaining medical certificates (or opin...

Are Your Medical Device Products Affected? MFDS Korea Adds 4 New Device Types and a Class Change

Image
The Ministry of Food and Drug Safety (MFDS) has revised the  Regulation on Medical Device Groups and Class by Group  to improve the efficiency of medical device safety management. The revision addresses issues identified during the review and approval processes for medical device licensing, evaluation, and civil service handling. ( Notification No. 2026-18 ) The amendment took effect on March 9, 2026. Key Revisions 1. New Medical Device Subcategories Myopia control lens Vertebral body replacement implant Fixative system for laminoplasty and laminectomy Sustained Release Drug Delivery 2. Medical Device Class Adjustment impression, pre-treatment material, gingival retraction cord: Class II → Class I Note : Medical devices are classified into four classes, from Class I (lowest risk) to Class IV (highest risk), based on their intended use and potential impact on the human body. GCA Korea provides expert support for global companies navigating Korea’s re...